Previous 10 | Next 10 |
In today's market, it is easy to overlook a stock like ADMA Biologics ( ADMA ), which has barely moved even as the market has continued to shoot up. However, despite its boring appearance, ADMA actually has a really compelling "high probability" bull case that should play out over the next 1-2...
Puhui Wealth Investment Management (NASDAQ: PHCF ) +70% . More news on: Puhui Wealth Investment Management Co., Ltd., IZEA Worldwide, Inc., Cumulus Media Inc., Stocks on the move, , Read more ...
RAMSEY, N.J. and BOCA RATON, Fla., June 23, 2020 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA”), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics, today announced that t...
RAMSEY, N.J. and BOCA RATON, Fla., May 27, 2020 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived bio...
CleanSpark (NASDAQ: CLSK ) +38% . More news on: CleanSpark, Inc., Aurora Cannabis Inc., IMV Inc., Stocks on the move, , , Read more ...
ADMA Biologics (NASDAQ: ADMA ) is up 8% premarket on increased volume in reaction to its announcement that subsidiary ADMA BioCenters Georgia has started collecting convalescent plasma from people who have recovered from COVID-19. More news on: ADMA Biologics, Inc., Healthcare ...
RAMSEY, N.J. and BOCA RATON, Fla., May 21, 2020 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA”), today announced it has commenced the collection of convalescent plasma through its wholly-owned subsidiary, ADMA BioCenters Georgia Inc. (“ADMA BioCenters...
The following slide deck was published by ADMA Biologics, Inc. in conjunction with their 2020 Q1 earnings Read more ...
Gainers: Tetraphase Pharmaceuticals (NASDAQ: TTPH ) +90% . More news on: Tetraphase Pharmaceuticals, Inc., ION Geophysical Corporation, Twilio Inc., Stocks on the move, , Read more ...
Image source: The Motley Fool. ADMA Biologics Inc (NASDAQ: ADMA) Q1 2020 Earnings Call May 6, 2020 , 4:30 p.m. ET Operator Continue reading
News, Short Squeeze, Breakout and More Instantly...
2024-05-10 11:30:04 ET Raymond James analyst issues STRONG BUY recommendation for ADMA on May 10, 2024 09:52AM ET. The previous analyst recommendation was Strong Buy. ADMA was trading at $8.705 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...